New York, May 29 (FinanceEnquiry.com) – Analysts at Cantor Fitzgerald initiate BUY rating on the shares of Cross Country Healthcare (NASDAQ: CCRN). The 12-month target price is set to $6. In a research note published on May 29 , the analysts mentio...